Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

14

Revenue 2017

Opdivo

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Opdivo was produced by Gilead Sciences.

Innate Pharma and AstraZeneca take monalizumab into phase 3

Innate Pharma and AstraZeneca take monalizumab into phase 3

Opdivo. “This is an important scientific milestone as we continue to invest in innovation and advance our late-stage clinical development pipeline,” said Mondher Mahjoubi (pictured below), chief executive officer of

France’s Innate Pharma eyes $100m Nasdaq IPO

France’s Innate Pharma eyes $100m Nasdaq IPO Bristol-Myers Squibb's Opdivo, but its first efforts – centred on CTLA4 inhibitor tremelimumab – have ended in failure.

Breath test could predict response to immunotherapy

Breath test could predict response to immunotherapy Patients were either on Keytruda or Opdivo. The results found that the device was able to aid in differentiating between patients response at three months of anti-PD-1 treatment. ... It is locked in a market battle with Opdivo, which  contributed

Encouraging signs in biomarker R&D

Encouraging signs in biomarker R&D In June 2018, Bristol Myers-Squibb sought approval for Opdivo and low-dose Yervoy in lung cancer in patients with a TMB of greater than ten mutations per megabase. ... impact of Opdivo plus Yervoy on OS in first-line NSCLC patients’.

Third strike for BMS’ Opdivo in brain cancer

Third strike for BMS’ Opdivo in brain cancer Despite failing first endpoint, trial is set to continue. Bristol-Myers Squibb’s (BMS) immuno-oncology blockbuster Opdivo has failed a third straight clinical trial in the hard-to-treat brain ... Opdivo plus standard first-line temozolomide and

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

PANDAS/PANS Awareness: A parent’s story
To help raise awareness of these often underdiagnosed diseases, Jon Hallows, Joint MD at Porterhouse shares his own experience as a parent of a son recently diagnosed with PANDAS...
Iskra Reic
Leading AstraZeneca’s return to growth in Europe
PME talks to Iskra Reic, the company’s head of Europe and Canada...
The era of digital wellbeing
Social media - friend or foe?...

Infographics